Intratio
Loading...
Skip to main content
Model output · Signal date 2026-10-13

Cigna Group (CI) Stock Forecast Oct. 13, 2026

Analysis updated on Oct. 13, 2026 (UTC) · Alpha · vs marketSwitch to Total · NYSE

Follow Unlock full AI forecasts
Rating · 90D ▲ Bullish Exact rating locked
90-day forecast Sign up free to reveal
30-day forecast Alpha
Rank in coverage Top 35% of 4004 stocks scored
Rank correlation · 90D n/a No per-ticker sample yet
Market Cap $74.66B large-cap · #3 of 10 peers
Summary

Cigna Group (CI) stock forecast summary

Our AI ranks Cigna Group outside the neutral middle of its coverage (a directional signal). Create a free account and follow it to see the exact price target.

Cigna Group is a large-cap company with a market capitalization of $74.66B. It ranks number 3 by market capitalization among the 10 Hospital & Medical Service Plans issuers in our coverage with a current forecast.

A per-ticker accuracy statistic for CI is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report

Expected return relative to the market over the horizon: a positive alpha means the model expects the stock to beat the market, whatever the market does. Ratings: strong buy ≥ +1.2%, buy ≥ +0.5%, sell < -0.6%, strong sell < -1.8% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-10-14 signals)

A free account shows the exact forecast, rating and rank of 3 tickers you follow, CI included.

Follow CI free
Price

CI price chart and AI forecast

CI
Cross-section · 2026-10-14

How CI ranks among 4004 stocks

90D Alpha forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).

Fundamentals

Cigna Group (CI) fundamentals

Trailing twelve months. The industry median and the rank (1 = highest) are taken over the Hospital & Medical Service Plans peers listed below that report each metric.

Valuation & Market

MetricCIIndustry medianRank
Market Cap $74.66B $22.48B 3/10
P/E Ratio 11.64x 18.94x 5/5
P/B Ratio 1.75x 2.74x 9/10
Dividend Yield 2.18% – –
EPS $24.17 – –
Book Value/Share $161.29 – –
Revenue/Share $1068.66 – –

Profitability & Margins

MetricCIIndustry medianRank
ROE 15.1% 8.6% 2/8
ROA 4.1% 3.2% 3/8
ROIC 9.8% 6.9% 3/10
Gross Margin 20.6% 54.6% 4/6
Operating Margin 3.5% 1.7% 3/10
Net Margin 2.3% 1.9% 4/8
EBT Margin 3.1% 1.4% 3/10
Tax Rate 19.2% – –

Financial Health

MetricCIIndustry medianRank
Current Ratio 0.85x 1.51x 9/10
Quick Ratio 0.74x – –
D/E Ratio 2.68x 2.38x 4/10
Financial Leverage 3.69x 3.42x 4/10
Interest Coverage 7.5x 7.5x 5/9
Working Capital -$8.57B $580M 9/10

Cash Flow

MetricCIIndustry medianRank
Operating Cash Flow $10.28B $3.13B 2/10
OCF Growth YoY 94.2% 34.4% 4/9

Operational Efficiency

MetricCIIndustry medianRank
Asset Turnover 1.80x 2.12x 6/10
Receivables Turnover 9.2x 18.1x 6/6
Inventory Turnover 38.3x – –
Fixed Assets Turnover 75.6x 72.4x 5/10
Days Sales Outstanding 40 days 21 days 1/6
Days Inventory 10 days – –
Payables Period 17 days – –
Cash Conversion Cycle 32 days – –

Income Statement

MetricCIIndustry medianRank
Total Revenue $282.38B $90.86B 2/10
Operating Income $9.96B $416M 2/10
Net Income $6.42B $840M 2/8
SG&A Expense $14.16B $13.59B 4/8
Cost of Goods Sold $224.13B $30.37B 1/6

Dividend & Shareholder Information

MetricCIIndustry medianRank
Dividends Per Share $6.15 – –
Payout Ratio 25.4% – –
Shares Outstanding 264M – –

Balance Sheet Highlights (USD millions)

Total Current Assets$46.99B29.9% of assets
Cash & Short-term Investments$6.30B4.0% of assets
Accounts Receivable$30.80B19.6% of assets
Inventory$5.85B3.7% of assets
Total Liabilities$114.17B72.7% of assets
Short-term Debt$45.15B28.7% of assets
Quarterly Financial Reports

CI quarterly financials and insider trading

Industry Peers · Hospital & Medical Service Plans

Cigna Group (CI) industry peers

Companies classified under the same SEC industry code as Cigna Group (Hospital & Medical Service Plans): 10 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.

Reveal all forecasts · See exact % predictions for all competitors

Sign up free
Company 90-Day AI Forecast (Alpha) Market Cap P/E Ratio P/B Ratio
CI Cigna Group ▲ $74.66B 11.6x 1.8x
UNH Unitedhealth Group Inc ▲ $339.08B 24.0x 3.4x
ELV Elevance Health, Inc. ▲ $92.23B 18.6x 2.1x
HUM Humana Inc ▲ $50.47B 39.8x 2.4x
CNC Centene Corp ▲ $34.02B – 1.5x
MOH Molina Healthcare, Inc. ▲ $10.94B – 2.6x
OSCR Oscar Health, Inc. ▲ $10.43B 18.9x 5.1x
CLOV Clover Health Investments, Corp. /De ▲ $2.55B – 6.8x
ALHC Alignment Healthcare, Inc. ▲ $1.72B – 6.5x
TRUP Trupanion, Inc. ▼ $1.17B – 2.9x

Where CI sits on the market map

Finance · Hospital & Medical Service Plans
Explore the map →
News

Cigna Group (CI) stock news

Loading...

FAQ

Cigna Group (CI) stock forecast FAQ

What is the Cigna Group (CI) stock forecast?

Our AI ranks Cigna Group outside the neutral middle of its coverage (a directional signal). Create a free account and follow it to see the exact price target.

How accurate are Cigna Group stock predictions?

A per-ticker accuracy statistic for CI is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report

How often are Cigna Group forecasts updated?

Cigna Group forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Oct. 13, 2026.

Which companies are Cigna Group's industry peers?

10 issuers in our coverage, CI included, share the SEC industry code Hospital & Medical Service Plans. The largest are: Unitedhealth Group Inc (UNH), Elevance Health, Inc. (ELV), Humana Inc (HUM), Centene Corp (CNC), Molina Healthcare, Inc. (MOH), Oscar Health, Inc. (OSCR).

This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.